Physical Activity Promotion for Breast and Endometrial Cancer Survivors
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to help breast and endometrial cancer survivors increase their physical activity through innovative technology. Participants begin with a Fitbit and online health integration to track their progress. If initial responses are insufficient, additional support such as online gym access or coaching calls may be provided. The trial targets women diagnosed with certain cancer stages in the past five years who currently engage in less than an hour of exercise per week. Participants must have internet access and be comfortable using a smartphone. As an unphased trial, this study offers a unique opportunity for participants to enhance their health with personalized support and cutting-edge technology.
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications. However, you may still be undergoing endocrine or Her2 therapies while participating.
What prior data suggests that this physical activity intervention is safe for breast and endometrial cancer survivors?
Research shows that exercise is generally safe for cancer survivors and can enhance their quality of life and health. Studies have found that breast and endometrial cancer survivors respond well to using a Fitbit connected to electronic health records. Participants in these studies received weekly feedback on their progress without major issues.
For those needing extra support, joining an online gym program has proven successful for endometrial cancer survivors, allowing them to exercise at home without significant problems. Additionally, coaching calls have been safe and effective, with many cancer survivors consistently attending wellness coaching sessions.
Overall, these activities are safe and well-received, offering promising ways to help cancer survivors become more active.12345Why are researchers excited about this trial?
Researchers are excited about this trial because it explores innovative ways to boost physical activity among breast and endometrial cancer survivors. Unlike traditional exercise programs, this approach integrates technology by using Fitbit activity trackers connected to electronic health records (EHR), allowing participants to receive personalized messages through their patient portal. For participants who don't initially respond, the trial uniquely offers "stepped-up" options, like access to an online gym or personalized coaching calls, tailoring the intervention to individual needs. This combination of wearable tech and personalized support could lead to more effective and engaging ways for survivors to maintain healthy activity levels.
What evidence suggests that this trial's treatments could be effective for breast and endometrial cancer survivors?
Research has shown that exercise can benefit cancer survivors by enhancing physical abilities, reducing cancer-related symptoms, and improving overall quality of life. In this trial, all participants will initially receive a Fitbit with electronic health records (EHR) integration to track progress and encourage increased activity. Participants needing more support will be randomized to receive additional interventions. One option is joining an online gym, which may not improve overall quality of life but does enhance physical fitness. Another option is coaching calls, which have been shown to reduce stress and improve communication, aiding survivors in better health management. These activities aim to support cancer survivors in staying active and healthy.24678
Who Is on the Research Team?
Kristen Pickett, Ph.D.
Principal Investigator
University of Wisconsin, Madison
Siobhan Phillips, Ph.D., MPH
Principal Investigator
Northwestern University, Chicago
Are You a Good Fit for This Trial?
This trial is for female adults over 18 who've had Stage I-III breast or Stage I-II Type 1 endometrial cancer and are at least 3 months post primary treatment. They should be doing less than 60 minutes of moderate exercise per week, have internet access, speak English, and can attend study visits in Wisconsin or Chicago. Those with severe health issues preventing exercise or other conflicting conditions cannot join.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Minimal Intervention
Participants receive a Fitbit activity tracker with EHR integration, including messages delivered via the EHR's patient portal. Evaluated for response/non-response every 4 weeks until week 20.
Augmentation Phase
Non-responders are randomized to receive either online gym access or coaching calls as additional support.
Follow-up
Participants are monitored for safety and effectiveness after treatment, with primary outcomes measured at 6, 12, and 30 months.
What Are the Treatments Tested in This Trial?
Interventions
- Physical Activity Promotion
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Wisconsin, Madison
Lead Sponsor
Northwestern University
Collaborator
National Cancer Institute (NCI)
Collaborator